Skip to main content
SpringerLink
Log in

Thyroid Cancer Multidisciplinary Team and the Organizational Paradigm

  • Chapter
Practical Management of Thyroid Cancer

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Kuhn TS. The Structure of Scientific Revolutions, 2nd edn, Enlarged, Vol 2, No 2 National Encyclopaedia of Unified Science. Chicago: The University of Chicago Press, 1970: 79.

    Google Scholar 

  2. Voltaire FMA. Candide, translated by John Butt. London: Penguin Books, 1947.

    Google Scholar 

  3. Rossi RL, Majlis S, Rossi RM. Thyroid cancer. Surg Clin North Am 2000; 80:571–580.

    Article  PubMed  CAS  Google Scholar 

  4. Teppo L, Hakulinen E and Eurocare Working Group. Variation in survival of adult patients with thyroid cancer in Europe. Eur J Cancer 1998; 34(14):2238–2252.

    Article  Google Scholar 

  5. Vanderpump MPJ, Alexander L, Scarpellow JHB, Clayton RM. An audit of management of thyroid cancer in a district general hospital. Clin Endocrinol 1998; 48:419–424.

    Article  CAS  Google Scholar 

  6. Kumar H, Daykin J, Holder R, Watkinson JC, Sheppard MC, Franklyn JA. An audit of the management of differentiated thyroid cancer in specialist and non-specialist clinical settings. Clin Endocrinol 2001; 54:719–723.

    Article  CAS  Google Scholar 

  7. Management of Thyroid Cancer in the Northern and Yorkshire Region, 1998–1999. Executive Report June 2004. Northern and Yorkshire Cancer Registry and Information Service. www.nycris.org.uk.

    Google Scholar 

  8. Hundahl SA, Fleming ID, Fremgen AM, Menck HR. A National Cancer Data Base report on 53 856 cases of thyroid carcinoma treated in the US, 1985–1995. Cancer 1998; 83(12):2638–2648.

    Article  PubMed  CAS  Google Scholar 

  9. Hundahl SA, Cady B, Cunningham MP, et al. Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the United States during 1996. US and German Thyroid Cancer Study Group. An American College of Surgeons Commission on Cancer Patient Care Evaluation Study. Cancer 2000; 89(1): 202–217.

    Article  PubMed  CAS  Google Scholar 

  10. Holzer S, Reiners C, Mann K, et al. Patterns of care for patients with primary differentiated carcinoma of the thyroid gland treated in Germany during 1996. US and German Thyroid Cancer Group. Cancer 2000; 89(1):192–201.

    Article  PubMed  CAS  Google Scholar 

  11. Hoelzer S, Steiners D, Bauer R, et al. Current practice of radioiodine treatment in the management of differentiated thyroid cancer in Germany. Eur J Nucl Med 2000; 27(10):1465–1472.

    Article  PubMed  CAS  Google Scholar 

  12. Birkmeyer JD. Understanding surgeon performance and improving patient outcomes. J Clin Oncol 2004; 22(14):2765–2766.

    Article  PubMed  Google Scholar 

  13. Sosa JA, Bowman HM, Tielach JM, Powe NR, Gordon TA, Udelsman R. The importance of surgeon experience for clinical and economic outcomes from thyroidectomy. Ann Surg 1998; 228:320–328.

    Article  PubMed  CAS  Google Scholar 

  14. Lamade W, Renz K, Willeke F, Klar E, Herfarth C. Effect of training on the incidence of nerve damage in thyroid surgery. Br J Surg 86:388–391.

    Google Scholar 

  15. Smith TJ, Hillner BE, Bear HD. Taking action on the volume-quality relationship: How long can we hide our heads in the colostomy bag? J Natl Cancer Inst 2003; 95(10):695–697.

    PubMed  Google Scholar 

  16. Zarnegar R, Brunaud L, Clark OH. Prevention, evaluation and management of complications following thyroidectomy for thyroid carcinoma. Endocrinol Metab Clin North Am 2003; 32(2):483–502.

    Article  PubMed  Google Scholar 

  17. Wang L. The volume-outcome relationship: Busier hospitals are indeed better, but why? J Natl Cancer Inst 2003; 95(10):700–702.

    Article  PubMed  Google Scholar 

  18. Kuijpens JL, Hansen B, Hamming JF, Ribot JG, Haak HR, Coebergh J-WW. Trends in treatment and long-term survival of thyroid cancer in Southeastern Netherlands, 1960–1992. Eur J Cancer 1998; 34(8):1235–1241.

    Article  PubMed  CAS  Google Scholar 

  19. The NHS Cancer Plan, Three year progress report. Maintaining the momentum. Department of Health, October 2003; The NHS Cancer Plan 2000. www.dh.gov.uk/cancer.

    Google Scholar 

  20. Improving Outcomes in Head and Neck Cancer. The Manual, November 2004. National Institute of Clinical Excellence: www.nice.org.uk.

    Google Scholar 

  21. British Thyroid Association. Guidelines for the management of thyroid cancer in adults. London: Royal College of Physicians, 2002.

    Google Scholar 

  22. Vini L, Harmer C. Management of thyroid cancer. Lancet Oncol 2002; 3(7):407–414.

    Article  PubMed  Google Scholar 

  23. Mallick UK, Lucraft HH, Proud G, et al. Optimising the management of differentiated thyroid cancer. Clin Oncol 2000; 12:363–364.

    CAS  Google Scholar 

  24. Sherman SI. Thyroid carcinoma. Lancet 2003; 361(9356): 501–511.

    Article  PubMed  Google Scholar 

  25. Tuttle M, Robbins R, Larsen SM. Challenging cases in thyroid cancer:A multidisciplinary approach. Eur J Nucl Med Mol Imaging 2004, 31(4):605–612.

    Article  PubMed  Google Scholar 

  26. Northern Cancer Network Site Specific Thyroid Cancer Group. Management guidelines for thyroid cancer. Newcastle upon Tyne: NCN. Clin Oncol 2000; 12:373–391.

    Google Scholar 

  27. Delisle MJ, Schvartz C, Theobald S, Maes B, Vaudrey C, Pochart JM. Cancers of the thyroid. Value of a regional registry on 627 patients diagnosed, treated and followed by a multidisciplinary team. Ann Endocrinol 1996; 57(1):41–49.

    CAS  Google Scholar 

  28. Kondo T, Tomita K. Thyroid tumour clinical path. Nippon Jibiinkoka Gakkai Kaiho 2001; 104(10):1017–1024.

    PubMed  CAS  Google Scholar 

  29. AACE/AAES Medical/Surgical Guidelines for Clinical Practice: Management of Thyroid Carcinoma, Endocr Pract 2001; 7(3):200–220.

    Google Scholar 

  30. National Comprehensive Cancer Network. 2003. www.NCCN.org.

    Google Scholar 

  31. The Manual of Cancer Services Standards — July 2004: www.dh.gov.uk/cancer.

    Google Scholar 

  32. National Manual of Quality Measures for Cancer Peer Review 2004. www.dh.gov.uk/policyandguidance.

    Google Scholar 

  33. Mallick UK, Charalambous H. Current issues in the management of differentiated thyroid cancer Nucl Med Commun 2004; 25(9):873–881.

    Article  PubMed  Google Scholar 

  34. Sawka AM, Thephamongkhol K, Brouwers M, Thabane L, Browman G, Gerstein H. A systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well differentiated thyroid cancer. J Clin Endocrinol Metab 2004; 89(8):3668–3678.

    Article  PubMed  CAS  Google Scholar 

  35. Mazzaferri E. A randomised trial of remnant ablation — in search of an impossible dream. J Clin Endocrinol Metab 2004; 89(8):3662–3664.

    Article  PubMed  CAS  Google Scholar 

  36. Spencer CA. Challenges of serum thyroglobulin (Tg) measurement in the presence of Tg autoantibodies. J Clin Endocrinol Metab 2004; 89(8):3702–3704.

    Article  PubMed  CAS  Google Scholar 

  37. Mazzaferri EL, Robbins RJ, Spencer CA, et al. A consensus report of the role of serum thyroglobulin as a monitoring method for low risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 2003; 88(4): 1433–1441.

    Article  PubMed  CAS  Google Scholar 

  38. Schlumberger M, Berg G, Cohen O, et al. Follow-up of low risk patients with differentiated thyroid carcinoma: a European perspective. Eur J Endocrinol 2004; 150:105–112.

    Article  PubMed  CAS  Google Scholar 

  39. International Cancer Research Portfolio — www.cancerportfolio.org.

    Google Scholar 

  40. Mazzaferri EL, Kloos RT. Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 2001; 86:1447–1463.

    Article  PubMed  CAS  Google Scholar 

  41. Clark OH, Levin K, Zeng QH, et al. Thyroid cancer: the case for total thyroidectomy. Eur J Cancer Clin Oncol 1988; 24:305–313.

    Article  PubMed  CAS  Google Scholar 

  42. Hay ID, Grant CS, Bergstralh EJ, et al. Unilateral total lobectomy: is it sufficient surgical treatment for patients with AMES low-risk papillary thyroid carcinoma? Surgery 1998; 124:958–966.

    PubMed  CAS  Google Scholar 

  43. Cady B. Our AMES is true: How an old concept still hits the mark: or, risk group assignment points the arrow to rational therapy selection in differentiated thyroid cancer. Am J Surg 1997; 174:462–468.

    Article  PubMed  CAS  Google Scholar 

  44. Hay ID. Papillary thyroid carcinoma. Endocrinol Metab Clin North Am 1990; 19:545–576.

    PubMed  CAS  Google Scholar 

  45. Bal C, Padhy AK, Jana S, et al. Prospective randomized clinical trial to evaluate the optimal dose of 131I for remnant ablation in patients with differentiated thyroid carcinoma. Cancer 1996; 77:2574–2580.

    Article  PubMed  CAS  Google Scholar 

  46. Bal CS, Kumar A, Pant GS. Radioiodine dose for remnant ablation in differentiated thyroid carcinoma: a randomized clinical trial in 509 patients. J Clin Endocrinol Metab 2004; 89:1666–1673.

    Article  PubMed  CAS  Google Scholar 

  47. Creutzig H. High or low dose radioiodine ablation of thyroid remnants? Eur J Nucl Med 1987; 12:500–502.

    Article  PubMed  CAS  Google Scholar 

  48. Johansen K, Woodhouse NJ, Odugbesan O. Comparison of 1073 MBq and 3700 MBq iodine-131 in postoperative ablation of residual thyroid tissue in patients with differentiated thyroid cancer. J Nucl Med 1991; 32:252–254.

    PubMed  CAS  Google Scholar 

  49. Doi SA, Woodhouse NJ. Ablation of the thyroid remnant and 131I dose in differentiated thyroid cancer. Clin Endocrinol (Oxf) 2000; 52:765–773.

    Article  CAS  Google Scholar 

  50. Schlumberger MJ. Medical progress — Papillary and follicular thyroid carcinoma. N Engl J Med 1998; 338:297–306.

    Article  PubMed  CAS  Google Scholar 

  51. Schlumberger M, Mancusi F, Baudin E, et al. 131-I Therapy for elevated thyroglobulin levels. Thyroid 1997; 7:273–276.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Northern Centre for Cancer Treatment, Newcastle General Hospital, Newcastle upon Tyne

    Ujjal K. Mallick MS, FRCR

  2. Northern Cancer Network Thyroid Cancer Group, UK

    Ujjal K. Mallick MS, FRCR

Authors
  1. Ujjal K. Mallick MS, FRCR
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. The Ohio State University, Columbus, OH, USA

    Ernest L. Mazzaferri MD, MACP (Emeritus Professor) (Emeritus Professor)

  2. University of Florida, Gainsville, FL, USA

    Ernest L. Mazzaferri MD, MACP (Emeritus Professor) (Emeritus Professor)

  3. Department of Radiotherapy, Royal Marsden Hospital, London, UK

    Clive Harmer FRCR, FRCP (Head of Thyroid Unit) (Head of Thyroid Unit)

  4. Northern Centre for Cancer Treatment, Newcastle upon Tyne, UK

    Ujjal K. Mallick MS, FRCR (Vice-Chair) (Vice-Chair)

  5. Thyroid Cancer Subgroup, National Cancer Research Institute, UK

    Ujjal K. Mallick MS, FRCR (Vice-Chair) (Vice-Chair)

  6. Northern Cancer Network Thyroid Cancer Group, UK

    Ujjal K. Mallick MS, FRCR (Vice-Chair) (Vice-Chair)

  7. Department of Medicine, University of Newcastle upon Tyne, UK

    Pat Kendall-Taylor MD, FRCP (Emeritus Professor) (Emeritus Professor)

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag London Limited

About this chapter

Cite this chapter

Mallick, U.K. (2006). Thyroid Cancer Multidisciplinary Team and the Organizational Paradigm. In: Mazzaferri, E.L., Harmer, C., Mallick, U.K., Kendall-Taylor, P. (eds) Practical Management of Thyroid Cancer. Springer, London. https://doi.org/10.1007/1-84628-013-3_3

Download citation

  • DOI: https://doi.org/10.1007/1-84628-013-3_3

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-85233-910-4

  • Online ISBN: 978-1-84628-013-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation